CYTK financial statements

The full income statement, balance sheet, and cash-flow statement for Cytokinetics Incorporated (CYTK), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 109.2M2024-09 118.0M2024-12 118.4M2025-03 119.4M2025-06 119.7M2025-09 122.3M2025-12 123.2M2026-03 124.4M2026-06 132.1M+20.9% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeYoYQoQFiguresAs-reported fiscal years.

Line item	FY2025	FY2024	FY2023	FY2022	FY2021
Income Statement	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Revenue	88.0M YoY+376.6%	18.5M YoY+145.3%	7.53M YoY-92.0%	94.6M YoY+34.3%	70.4M YoY+26.2%
	700M YoY+26.2%	555M YoY+10.1%	504M YoY+20.3%	419M YoY+63.1%	257M YoY+71.4%
Research & development	416M YoY+22.6%	339M YoY+2.8%	330M YoY+37.1%	241M YoY+50.6%	160M YoY+65.0%
Selling, general & administrative	284M YoY+32.0%	215M YoY+24.0%	174M YoY-2.5%	178M YoY+83.9%	96.8M YoY+83.3%
General & administrative	284M YoY+32.0%	215M YoY+24.0%	174M YoY-2.5%	178M YoY+83.9%	96.8M YoY+83.3%
Operating income	-612M YoY-14.2%	-536M YoY-8.1%	-496M YoY-53.1%	-324M YoY-74.0%	-186M YoY-98.3%
Interest expense	45.6M YoY+20.9%	37.7M YoY+33.2%	28.3M YoY+45.8%	19.4M YoY+18.1%	16.4M YoY+3.0%
Interest & investment income	—	—	—	11.4M YoY+1040.0%	1.00M YoY-81.1%
Other non-operating income	48.4M YoY-6.0%	51.5M YoY+86.5%	27.6M YoY+143.6%	11.3M YoY+3326.6%	331K YoY-93.8%
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	-785M YoY-33.2%	-590M YoY-12.0%	-526M YoY-35.3%	-389M YoY-80.6%	-215M YoY-69.2%
	-$6.54 YoY-24.3%	-$5.26 YoY+3.5%	-$5.45 YoY-25.9%	-$4.33 YoY-54.6%	-$2.80 YoY-42.1%
EPS (basic)	-$6.54 YoY-24.3%	-$5.26 YoY+3.5%	-$5.45 YoY-25.9%	-$4.33 YoY-54.6%	-$2.80 YoY-42.1%
	120M YoY+7.3%	112M	—	—	—
	120M YoY+7.3%	112M	—	—	—
Balance Sheet	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	917M YoY-17.2%	1.11B YoY+76.4%	628M YoY-21.0%	795M YoY+48.4%	536M YoY+13.0%
Cash & equivalents	123M YoY+29.2%	94.9M YoY-16.1%	113M YoY+72.3%	65.6M YoY-41.8%	113M YoY+35.8%
Cash & short-term investments	1.20B YoY+0.0%	1.20B YoY+83.1%	655M YoY-21.0%	829M YoY+33.0%	624M YoY+24.5%
Accounts receivable	17.8M YoY+6.7%	16.6M YoY+1197.7%	1.28M YoY+772.8%	147K YoY-99.7%	51.8M YoY+1072.4%
Inventory	0.00	—	—	—	—
Prepaid expenses	17.0M YoY+11.2%	15.3M YoY+27.9%	11.9M YoY-4.2%	12.5M YoY+2.0%	12.2M YoY+112.8%
	1.42B YoY+1.6%	1.40B YoY+70.0%	824M YoY-18.8%	1.01B YoY+20.6%	841M YoY+57.6%
Property, plant & equipment	79.2M YoY+20.3%	65.8M YoY-4.3%	68.7M YoY-14.5%	80.5M YoY+9.8%	73.3M YoY+449.0%
Operating lease right-of-use	76.0M YoY+1.1%	75.2M YoY-4.8%	79.0M YoY-4.5%	82.7M YoY+13.1%	73.1M YoY+2401.3%
Other non-current assets	17.3M YoY+125.1%	7.71M YoY-3.6%	8.00M YoY-17.5%	9.69M YoY+34.8%	7.19M YoY+13.1%
	202M YoY+12.7%	180M YoY+75.0%	103M YoY+21.3%	84.6M YoY+17.8%	71.9M YoY+130.3%
Accounts payable	22.3M YoY+9.7%	20.4M YoY-5.3%	21.5M YoY-16.0%	25.6M YoY+21.5%	21.1M YoY+162.0%
Accrued liabilities	83.3M YoY+50.5%	55.3M YoY+29.7%	42.6M YoY-3.3%	44.1M YoY+28.3%	34.4M YoY+77.9%
Deferred revenue	1.61M YoY-96.9%	52.4M	0.00	—	—
Short-term & current debt	41.2M YoY+257.5%	11.5M YoY+14.3%	10.1M YoY+952.2%	958K	—
Current lease liability	19.1M YoY+0.7%	19.0M YoY+6.1%	17.9M YoY+39.5%	12.8M YoY-13.7%	14.9M YoY+433.7%
Other current liabilities	3.83M YoY-60.9%	9.81M YoY-7.1%	10.6M YoY+840.2%	1.12M YoY-27.1%	1.54M YoY+46.8%
	2.08B YoY+35.6%	1.54B YoY+27.0%	1.21B YoY+7.8%	1.12B YoY+87.9%	597M YoY+42.1%
Long-term debt	246M YoY+164.3%	93.2M YoY+59.7%	58.4M YoY-8.5%	63.8M YoY+34.7%	47.4M YoY+2.5%
Deferred revenue (non-current)	—	—	—	0.00 YoY-100.0%	87.0M YoY+0.0%
Non-current lease liability	108M YoY-4.1%	113M YoY-6.5%	120M YoY-5.1%	127M YoY+13.1%	112M YoY+25406.6%
Operating lease liability (total)	127M YoY-3.4%	132M YoY-4.9%	138M YoY-1.0%	140M YoY+9.9%	127M YoY+3840.8%
Finance lease liability (total)	—	204K YoY-82.2%	1.14M YoY-42.9%	2.00M YoY+53.3%	1.30M
Other non-current liabilities	—	0.00 YoY-100.0%	186K YoY-82.2%	1.04M YoY-76.6%	4.46M
	-660M YoY-387.3%	-135M YoY+65.0%	-386M YoY-258.0%	-108M YoY-144.2%	244M YoY+115.1%
Preferred stock	0.00	0.00	0.00	0.00	0.00
Common stock	123K YoY+4.2%	118K YoY+15.7%	102K YoY+8.5%	94.0K YoY+11.9%	84.0K YoY+20.0%
Additional paid-in capital	2.83B YoY+10.2%	2.56B YoY+48.6%	1.73B YoY+16.5%	1.48B YoY+2.0%	1.45B YoY+31.4%
Retained earnings	-3.49B YoY-29.1%	-2.70B YoY-27.9%	-2.11B YoY-33.2%	-1.59B YoY-31.3%	-1.21B YoY-21.7%
Accumulated other comprehensive income	630K YoY-73.7%	2.40M YoY+24080.0%	-10.0K YoY+99.7%	-3.59M YoY-313.1%	-869K YoY-683.2%
Total liabilities & equity	1.42B YoY+1.6%	1.40B YoY+70.0%	824M YoY-18.8%	1.01B YoY+20.6%	841M YoY+57.6%
	123M YoY+4.0%	118M YoY+16.3%	102M YoY+7.2%	94.8M YoY+11.8%	84.8M YoY+19.4%
	123M YoY+4.0%	118M YoY+16.3%	102M YoY+7.2%	94.8M YoY+11.8%	84.8M YoY+19.4%
	123M YoY+4.0%	118M YoY+15.0%	103M YoY+8.2%	95.2M YoY+12.1%	84.9M YoY+19.3%
Cash Flow	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
	-510M YoY-28.8%	-396M YoY+4.5%	-414M YoY-38.3%	-300M YoY-110.2%	-143M YoY-1693.7%
Depreciation & amortization	10.1M YoY+6.2%	9.53M YoY-19.9%	11.9M YoY+104.5%	5.81M YoY+155.4%	2.28M YoY+24.3%
Share-based compensation	112M YoY+14.8%	97.8M YoY+35.8%	72.1M YoY+50.6%	47.9M YoY+78.3%	26.8M YoY+52.3%
Change in receivables	1.11M YoY-92.8%	15.4M YoY+1252.7%	1.14M YoY+102.0%	-56.7M YoY-219.6%	47.4M YoY+6479.4%
	16.7M YoY+103.0%	-553M YoY-331.2%	239M YoY+191.3%	-262M YoY-77.4%	-148M YoY+24.8%
Capital expenditure	24.8M YoY+535.1%	3.91M YoY+175.8%	1.42M YoY-87.5%	11.3M YoY-76.8%	48.9M YoY+342.2%
Free cash flow	-535M YoY-33.8%	-400M YoY+3.8%	-416M YoY-33.7%	-311M YoY-62.4%	-191M YoY-8975.1%
Acquisitions	0.00	0.00	0.00	0.00	0.00
Sales/maturities of investments	1.10B YoY+48.3%	744M YoY-14.5%	871M YoY+44.0%	605M YoY+43.0%	423M YoY+71.0%
	524M YoY-43.6%	931M YoY+320.5%	221M YoY-57.1%	516M YoY+61.3%	320M YoY+36.7%
Long-term debt issued	0.00	0.00	0.00	0.00	0.00
Long-term debt repaid	10.8M YoY+24.5%	8.68M	0.00 YoY-100.0%	47.7M	0.00
Common stock issued	0.00	0.00 YoY-100.0%	164M	0.00	0.00
Common stock repurchased	0.00	0.00	0.00	0.00	0.00
Dividends paid	0.00	0.00	0.00	0.00	0.00
FX effect on cash	-715K YoY-442.1%	209K YoY+1145.0%	-20.0K	—	—
Net change in cash	30.4M YoY+267.3%	-18.2M YoY-139.3%	46.2M YoY+201.6%	-45.5M YoY-253.2%	29.7M YoY-36.2%
Interest paid	22.9M YoY-11.8%	26.0M YoY+152.3%	10.3M YoY-32.1%	15.2M YoY+65.3%	9.18M YoY-4.6%
Income taxes paid	0.00	0.00	0.00	—	—
Valuation Ratios	as ofDec 31 ’25	as ofDec 31 ’24	as ofDec 31 ’23	as ofDec 31 ’22	as ofDec 31 ’21
Market cap	7.83B YoY+40.5%	5.57B YoY-32.0%	8.19B YoY+88.8%	4.34B YoY+12.1%	3.87B YoY+161.7%
P/S	88.9× YoY-70.5%	301.5× YoY-71.2%	1047.5× YoY+3481.1%	29.3× YoY-46.7%	54.9× YoY+107.5%
P/B	—	—	—	—	15.9× YoY+21.7%
Source filing	10-K	10-K	10-K	10-K	10-K

About this data

Source: CYTK's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CYTK filings on SEC EDGAR → Not investment advice.